Gary Clark: Unfiltered
Insightful analysis on the financial currents, corporate maneuvers, and innovations defining our era.
About This Column
Gary Clark is a commentator and strategist exploring the intersection of finance and industrial transformation. Transitioning from his deep dive into corporate maneuvers, Gary now delivers daily dispatches on the broad forces defining the 2026 economic landscape - from the evolution of global supply chain finance to the impact of AI on asset allocation. With a reputation for providing "the story behind the numbers," he offers a unique lens on what drives market performance in a complex world. His writing is essential for anyone seeking to understand the "why" of today’s market to predict the "what" of tomorrow.
Displaying items 161-180 of 1034 in total
The New Front Line: How Libraries Became Essential Digital Infrastructure
The New Oral Health Gold Rush: A Bet on Bacteria and Virtual Care
Vida Health’s DiMe Seal: A New Stamp of Approval in Digital Health
ES Foundry's 3 GW Reality Check for the US Solar Supply Chain
Electra's High-Stakes Balancing Act: Funding a Battery Future via Dilution
Aligos Banks $25M in Strategic China Deal for a New Hepatitis B Attack
Beyond the Balance Sheet: A Winery's Radical New Model for Cancer Support
Mass. Eyes Financial Fluency with New AP Course Endorsement
America's Caregiving Crisis: The $600 Billion Shadow Economy
Ankle OA's Youth Crisis: New Guide Reveals More Questions Than Answers
Schouw & Co. Bets DKK 1.1B on Outdoor Apparel's Technical Ascent
AI, Capital, and Care: The High-Stakes Bet on Britain's Rehab Future
The $2.8M Bet on Rural Mothers: A Blueprint for American Healthcare?
AHN's Heritage Valley Deal: A Strategic Power Play in PA Healthcare
Empery Digital's Big Pivot: Trading Bitcoin Volatility for AI Real Estate
The Musk Manual: Can a Book Distill a Trillion-Dollar Mindset for the Masses?
Hop-on's Digitalage App Hits iOS, Vowing to Disrupt the Creator Economy
The $1.4 Trillion Guardrail: AI Governance Is the Market's Next Big Bet
Candel's High-Stakes Gamble on a Viral Therapy for Advanced Lung Cancer
